RemedyRepack Inc. is recalling 79 blister cards (30 count) of Metformin Hydrochloride Extended Release 750 mg, a prescription medication used to treat type 2 diabetes. The recall was initiated because testing detected N-Nitrosodimethylamine (NDMA) at levels higher than the acceptable daily intake set by the manufacturer. Consumers should not stop taking their medication without first consulting a healthcare provider, as the risk of untreated diabetes may outweigh the risk of exposure to the impurity.
The product contains N-Nitrosodimethylamine (NDMA), which is classified as a probable human carcinogen based on results from laboratory tests. Long-term exposure to levels above the acceptable intake limit could potentially increase the risk of cancer.
Pharmacy refund and medical consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.